|
SEVERABLE FUNDING FOR NCI-FREDERICK
|
261200800001E
|
$248,730,791
|
$1,181
|
UNKNOWN, UNKNOWN
|
LEIDOS BIOMEDICAL RESEARCH, INC.
|
|
ECOG-ACRIN NCORP Research Base
|
5UG1CA189828-05
|
$21,554,621
|
|
WAGNER, LYNNE
|
ECOG-ACRIN MEDICAL RESEARCH FOUNDATION
|
|
The Center for Therapeutic Targeting of EWS-oncoproteins
|
1U54CA231637-01
|
$12,500,000
|
|
STEGMAIER, KIMBERLY
|
DANA-FARBER CANCER INST
|
|
Breast Pre-Cancer Atlas Center
|
1U2CCA233254-01
|
$10,799,091
|
|
HWANG, EUN-SIL
|
DUKE UNIVERSITY
|
|
Precancer Atlas of Familial Adenomatous Polyposis
|
1U2CCA233311-01
|
$10,637,198
|
|
SNYDER, MICHAEL
|
STANFORD UNIVERSITY
|
|
Cancer Center Support Grant
|
5P30CA015704-41
|
$9,561,228
|
$95,612
|
GILLILAND, D
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Alliance NCORP Research Base
|
5UG1CA189823-05
|
$7,362,635
|
|
BUCKNER, JAN
|
MAYO CLINIC ROCHESTER
|
|
Pre-cancer atlases of cutaneous and hematologic origin (PATCH Center)
|
1U2CCA233262-01
|
$6,918,530
|
|
SORGER, PETER
|
HARVARD MEDICAL SCHOOL
|
|
The Lung PCA: A Multi-Dimensional Atlas of Pulmonary Premalignancy
|
1U2CCA233238-01
|
$6,692,860
|
|
SPIRA, AVRUM
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
|
An integrated approach to analyze and target EWS/FLI in Ewing sarcoma
|
1U54CA231641-01
|
$6,163,485
|
|
LESSNICK, STEPHEN
|
RESEARCH INST NATIONWIDE CHILDREN'S HOSP
|
|
University of California Minority Patient-Derived Xenograft (PDX) Development and Trial Center (UCaMP) to Reduce Cancer Health Disparities
|
1U54CA233306-01
|
$6,160,778
|
|
PAN, CHONG-XIAN
|
UNIVERSITY OF CALIFORNIA AT DAVIS
|
|
The Center for Synovial Sarcoma Biology and Therapeutics
|
1U54CA231638-01
|
$5,251,652
|
|
KADOCH, CIGALL
|
DANA-FARBER CANCER INST
|
|
Cancer Immunotherapy Trials Network Central Operations and Statistical Center
|
5UM1CA154967-08
|
$4,864,165
|
|
CHEEVER, MARTIN
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Childrens Oncology Group Pediatric Early Phase Clinical Trial Network
|
1UM1CA228823-01
|
$4,739,780
|
|
WEIGEL, BRENDA
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
Dual targeting of tumoral microenvironment and tumoral cells by blocking the IL-33/ST2 pathway
|
1U01CA232491-01
|
$4,129,375
|
|
PACZESNY, SOPHIE
|
INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS
|
|
Multispecific targeting incorporating cytokine receptor pathways in high risk pediatric acute leukemias to improve durability of adoptive cell therapy-induced remissions
|
1U01CA232486-01
|
$3,950,741
|
|
FRY, TERRY
|
UNIVERSITY OF COLORADO DENVER
|
|
Kaiser Permanente NCI National Community Oncology Research Program NCORP
|
5UG1CA189821-05
|
$3,178,650
|
|
SUGA, JENNIFER
|
KAISER FOUNDATION RESEARCH INSTITUTE
|
|
Wake Forest NCORP Research Base
|
5UG1CA189824-05
|
$3,106,081
|
|
LESSER, GLENN
|
WAKE FOREST UNIVERSITY HEALTH SCIENCES
|
|
Structural Cell Biology of DNA Repair Machines
|
5P01CA092584-18
|
$3,082,620
|
|
TAINER, JOHN
|
UNIVERSITY OF CALIF-LAWRENC BERKELEY LAB
|
|
Heartland Cancer Research NCORP
|
5UG1CA189830-05
|
$2,990,806
|
|
FALLER, BRYAN
|
DECATUR MEMORIAL HOSPITAL
|
|
Cassette exons in neoplastic pro-B-cells: implications for immunotherapy
|
1U01CA232563-01
|
$2,931,750
|
|
THOMAS-TIKHONENKO, ANDREI
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
Moffitt Cancer Center Support Grant
|
4P30CA076292-18
|
$2,930,104
|
$29,301
|
SELLERS, THOMAS
|
H. LEE MOFFITT CANCER CTR & RES INST
|
|
Long Term Multidisciplinary Study of Cancer in Women: The Nurses Health Study
|
5UM1CA186107-05
|
$2,867,003
|
|
STAMPFER, MEIR
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Accelerating Colorectal Cancer Screening and Follow-up through Implementation Science (ACCSIS) Program
|
1U24CA233218-01
|
$2,863,779
|
|
SUBRAMANIAN, SUJHA
|
RESEARCH TRIANGLE INSTITUTE
|
|
Enhancing Chimeric Antigen Receptor T Cell Therapies for Hematologic Malignancies: Beyond CART 19
|
5P01CA214278-02
|
$2,804,200
|
|
JUNE, CARL
|
UNIVERSITY OF PENNSYLVANIA
|
|
Cancer Research Consortium of West Michigan (CRCWM)
|
5UG1CA189860-05
|
$2,751,806
|
|
YOST, KATHLEEN
|
SPECTRUM HEALTH HOSPITALS
|
|
Lymphoma Specialized Program of Research Excellence (SPORE) in Human Cancer
|
5P50CA097274-17
|
$2,500,000
|
|
WEINER, GEORGE
|
UNIVERSITY OF IOWA
|
|
Mayo Clinic Breast Cancer SPORE
|
5P50CA116201-13
|
$2,471,635
|
|
GOETZ, MATTHEW
|
MAYO CLINIC ROCHESTER
|
|
The CSBC Research Center for Cancer Systems Immunology at MSKCC
|
5U54CA209975-03
|
$2,409,446
|
|
LESLIE, CHRISTINA
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
SPORE in Prostate Cancer
|
5P50CA180995-04
|
$2,289,160
|
|
CATALONA, WILLIAM
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
Weill Cornell Medicine (WCM) SPORE in Prostate Cancer
|
5P50CA211024-02
|
$2,283,108
|
|
RUBIN, MARK
|
WEILL MEDICAL COLL OF CORNELL UNIV
|
|
MD Anderson Gynecologic SPORE for Uterine Cancers
|
5P50CA098258-13
|
$2,268,692
|
|
LU, KAREN
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
COG NCTN Network Group Operations Center
|
3U10CA180886-05S1
|
$2,256,906
|
|
ADAMSON, PETER
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
SPORE in Cervical Cancer
|
5P50CA098252-15
|
$2,251,770
|
|
WU, TZYY-CHOOU
|
JOHNS HOPKINS UNIVERSITY
|
|
Mechanisms of Ethnic/Racial Differences in Lung Cancer Due to Cigarette Smoking
|
5P01CA138338-08
|
$2,222,937
|
|
HECHT, STEPHEN
|
UNIVERSITY OF MINNESOTA
|
|
Combinations of Synergistic Bispecific Human Antibodies: A Novel Strategy for the Treatment of Neuroblastoma
|
1U01CA232490-01
|
$2,200,000
|
|
OLSON, JAMES
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Modeling the Role of Lymph Node Metastases in Tumor-Mediated Immunosuppression
|
5U54CA209971-03
|
$2,142,192
|
|
PLEVRITIS, SYLVIA
|
STANFORD UNIVERSITY
|
|
Risk of Pediatric and Adolescent Cancer Associated with Medical Imaging
|
5R01CA185687-04
|
$2,139,085
|
|
SMITH-BINDMAN, REBECCA
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Systems Analysis of Epigenomic Architecture in Cancer Progression
|
5U54CA217297-02
|
$2,104,443
|
|
HUANG, TIM
|
UNIVERSITY OF TEXAS HLTH SCIENCE CENTER
|
|
Centers for Cancer Systems Therapeutics (CaST)
|
5U54CA209997-03
|
$2,090,840
|
|
CALIFANO, ANDREA
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Breast Cancer genetic study in African-ancestry populations
|
5R01CA202981-03
|
$2,090,789
|
|
ZHENG, WEI
|
VANDERBILT UNIVERSITY MEDICAL CENTER
|
|
Quantitative and functional characterization of therapeutic resistance in cancer
|
5U54CA217377-02
|
$2,054,998
|
|
MANALIS, SCOTT
|
MASSACHUSETTS INSTITUTE OF TECHNOLOGY
|
|
MOTILITY AND INVASION
|
5P01CA100324-16
|
$2,028,990
|
|
CONDEELIS, JOHN
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
Center on the Physics of Cancer Metabolism
|
5U54CA210184-03
|
$2,021,161
|
|
FISCHBACH, CLAUDIA
|
CORNELL UNIVERSITY
|
|
Genetics and Biology of Pancreatic Ductal Adenocarcinoma
|
5P01CA117969-13
|
$1,980,694
|
|
DEPINHO, RONALD
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
Biology and Transplantation of the Hematopoietic Stem Cell
|
5P01CA065493-24
|
$1,914,832
|
|
WAGNER, JOHN
|
UNIVERSITY OF MINNESOTA
|
|
Center for Cancer Nanotechnology Excellence for Translational Diagnostics (CCNE-TD)
|
5U54CA199075-04
|
$1,901,218
|
|
GAMBHIR, SANJIV
|
STANFORD UNIVERSITY
|
|
Systems analysis of phenotypic switch in control of cancer invasion
|
5U54CA209992-03
|
$1,893,994
|
|
LEVCHENKO, ANDRE
|
YALE UNIVERSITY
|
|
Roles and Regulation of wild-type and mutant forms of p53
|
5P01CA087497-17
|
$1,885,586
|
|
PRIVES, CAROL
|
COLUMBIA UNIV NEW YORK MORNINGSIDE
|
|
Center for Immunotherapeutic Transport Oncophysics
|
5U54CA210181-03
|
$1,865,321
|
|
FERRARI, MAURO
|
METHODIST HOSPITAL RESEARCH INSTITUTE
|
Total relevant funding to Contraception and Reproduction Research for this search: $1,348,387
|